Objective: Dosimetry studies have shown that activities of 131 I as small as 10-20 MBq may
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …

Introduction The aim of the study was to compare the success rate of an uptake-related
ablation protocol in which the dose depends on an I-131 24-h neck uptake measurement …

Purpose In an attempt to obviate the necessity for hospitalisation, the ablative dose of 131 I
in the treatment of thyroid cancer is divided into two or three fractions at weekly intervals in …

Purpose The residence time of 131 I in the blood is likely to be a measure of the amount of
131 I that is available for uptake by thyroid remnant tissue and thus the radiation absorbed …

Background Follow-up of 131 I whole-body scanning after 131 I ablation is associated with
potential stunning. Previous studies have suggested that, for scanning, 123 I is more …

Context: Published studies of thyroid stunning due to preablation 131I scanning in the
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …

PURPOSE: The optimal dose of I131 for ablation of functioning residual thyroid tissue after
surgery is controversial. The current study was conducted to determine the optimal dose of …

Purpose This article examines the outcome of radioactive iodine ablation therapy for thyroid
cancer in high-risk patients and investigates background factors influencing ablation failure …

Summary objective To evaluate the risk of performing inappropriate 131I ablative therapies
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …

Based on pre-therapy whole-body 131 I scintiscans showing only residual thyroid, 64
patients with differentiated thyroid cancer were treated with 1100 MBq (< 30 mCi) 131 I as …